Klebsiella pneumoniae: Development of carbapenem resistance due to acquisition of blaNDM-1 during antimicrobial therapy in twin infants with pneumonia

Frontiers in Microbiology

Volumn 6, Issue DEC, 2015, Pages

  Zhu, Junying ^a   Ding, Baixing ^b,c   Xu, Xiaogang ^b,c   Zhu, Demei ^b,c   Yang, Fan ^b,c   Zhang, Hong ^a   Hu, Fupin ^b,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Development of carbapenem resistance; In vivo; Klebsiella pneumoniae; Meropenem; NDM 1 metallo lactamase

Indexed keywords

CARBAPENEM; CEFOTAXIME; MEROPENEM; SULTAMICILLIN;

AMPLICON; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CASE REPORT; DNA FINGERPRINTING; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; MOLECULAR TYPING; MORBIDITY; MORTALITY; PNEUMONIA; POLYMERASE CHAIN REACTION;

EID: 84953883913     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01399     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention [CDCP] (2013). Antibiotic Resistance Threats. Available at: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
2. Chen, S. D., Hu, F. P., Xu, X. G., Liu, Y., Wu, W. H., Zhu, D. M., et al. (2011). High prevalence of KPC-2 type carbapenemase coupled with CTX-M type extended-spectrum β-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China. Antimicrob. Agents Chemother. 55, 2493-2494. doi: 10.1128/AAC.00047-11
3. Clinical and Laboratory Standards Institute [CLSI] (2014). Performance Standards for Antimicrobial Susceptibility Testing[S]: Twenty-fourth Informational Supplement. PA: CLSI.
4. Elliott, E., Brink, A. J., Greune, J., Els, Z., Woodford, N., Turton, J., et al. (2006). In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin. Infect. Dis. 42, e95-e98. doi: 10.1086/503264
5. Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., and Hughes, J. M. (1988). CDC definitions for nosocomial infections. Am. J. Infect. Control. 16, 128-140. doi: 10.1016/0196-6553(88)90053-3
6. Gasink, L. B., Edelstein, P. H., Lautenbach, E., Synnestvedt, M., and Fishman, N. O. (2009). Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect. Control. Hosp. Epidemiol. 30, 1180-1185. doi: 10.1086/648451
7. Hong, T., Moland, E. S., Abdalhamid, B., Hanson, N. D., Wang, J., Sloan, C., et al. (2005). Escherichia coli: development of carbapenem resistance during therapy. Clin. Infect. Dis. 40, e84-e86. doi: 10.1086/429822
8. Hu, F. P., Chen, S. D., Xu, X. G., Guo, Y., Liu, Y., Zhu, D. M., et al. (2012). Emergence of carbapenem-resistant Enterobacteriaceae clinical isolates from a teaching hospital in Shanghai, China. J. Med. Microbiol. 61, 132-136. doi: 10.1099/jmm.0.036483-0
9. Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., et al. (2010). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597-602. doi: 10.1016/S1473-3099(10)70143-2
10. Lledo, W., Hernandez, M., Lopez, E., Molinari, O. L., Soto, R. Q., Hernandez, E., et al. (2009). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. Morb. Mortal. Wkly Rep. 58, 256-260.
11. Logan, L. K. (2012). Carbapenem-resistant Enterobacteriaceae: an emerging problem in children. Clin. Infect. Dis. 55, 852-859. doi: 10.1093/cid/cis543
12. Qin, X. H., Yang, Y., Hu, F. P., and Zhu, D. M. (2014). Hospital clonal dissemination of Enterobacter aerogenes producing carbapenemase KPC-2 in a Chinese teaching hospital. J. Med. Microbiol. 63, 222-228. doi: 10.1099/jmm.0.064865-0
13. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233-2239.
14. Walsh, T. R., Weeks, J., Livermore, D. M., and Toleman, M. A. (2011). Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11, 355-362. doi: 10.1016/S1473-3099(11)70059-7
15. Zhang, R., Wang, X. D., Cai, J. C., Zhou, H. W., Lv, H. X., Hu, Q. F., et al. (2011). Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital. J. Med. Microbiol. 60, 977-982. doi: 10.1099/jmm.0.015826-0